The five most-read stories this month on Scope were:
Eating for good blood: Tips for boosting iron levels and hemoglobin: This entry from the Stanford Blood Center discusses hemoglobin levels and offers ways to boost levels prior to blood donation.
ME/CFS/SEID: It goes by many aliases, but its blood-chemistry signature is a giveaway: A multi-institution team published a study in Science Advances showing another physiological basis for a diagnosis of what it now being referred to as systemic exertion intolerance disease: a characteristic pattern, or “signature,” consisting of elevated levels of various circulating immune-signaling substances in the blood.
From Costa Rica to Stanford: Pediatric liver transplant surgeon shares his story: During a recent talk, Carlos Esquivel, MD, PhD, – known as one of the top pediatric liver transplant surgeons – told a gripping tale of his journey to Stanford.
“It’s not just science fiction anymore”: Childx speakers talk stem cell and gene therapy: At the Childx conference held here earlier this month, there was a great deal of optimism that stem cell and genetic therapies are about to have a huge impact on many childhood diseases.
Our most-shared story of the month: The first time I cried in a patient’s room
And still going strong – the most popular post from the past:
The mystery surrounding lung-transplant survival rates: A 2012 article in the San Francisco Chronicle provided a look at the challenges facing lung transplant patients and explored why a significant number don’t live beyond the five-year mark, despite improvements in survival rates.